Gastrointestinal Stromal Tumour (GIST) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
Condition: Gastrointestinal Stromal TumourInterventions: Drug: Regorafenib; Drug: imatinibSponsor: Australasian Gastro-Intestinal Trials GroupRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2014 Category: Research Source Type: clinical trials

A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
Condition: Gastrointestinal Stromal TumourInterventions: Drug: Regorafenib; Drug: imatinibSponsor: Australasian Gastro-Intestinal Trials GroupRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2014 Category: Research Source Type: clinical trials

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
Conditions: Gastrointestinal Stromal Tumors; KIT +; Resected Gastrointestinal Stromal Tumors; Non-metastatic; High Risk of RecurrenceIntervention: Drug: Imatinib maintenanceSponsor: Centre Leon BerardNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2014 Category: Research Source Type: clinical trials

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
Conditions: Gastrointestinal Stromal Tumors; KIT +; Resected Gastrointestinal Stromal Tumors; Non-metastatic; High Risk of RecurrenceIntervention: Drug: Imatinib maintenanceSponsor: Centre Leon BerardRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2014 Category: Research Source Type: clinical trials

ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors
Conditions: Upper Gastrointestinal Submucosal Tumors (SMTs); Gastrointestinal Stromal Tumors (GISTs); LeiomyomaInterventions: Procedure: ESTD; Procedure: VATSSponsors: Nanfang Hospital of Southern Medical University; Nanfang Hospital of Southern Medical UniversityRecruiting - verified December 2011 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2013 Category: Research Source Type: clinical trials